Mitochon Pharmaceuticals
PrivateLast Round
Grant
May 10, 2022
Total Funding Raised
$2.28M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mitochon Pharmaceuticals is a biotechnology company that develops drugs targeting the mitochondria to treat a host of serious diseases with significant unmet medical needs, including neurodegenerative and neuromuscular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mitochon Pharmaceuticals Comparables
Compare Mitochon Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Accuitis | 83% | |
| Lucy Therapeutics | 82% | |
| MitoChem Therapeutics, Inc. | 82% |
Mitochon Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 10, 2022 | ||||
| Grant | Sep 28, 2021 | ||||
| Grant | Oct 3, 2017 | ||||
| Seed | May 17, 2016 |
Mitochon Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Benjamin Franklin Technology Partners | Seed |
| Emily's Entourage | Grant |
| Cures Within Reach | Seed |
| BrightFocus Foundation | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Medical Technology Enterprise Consortium | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 48% MoM.
- Jul 29, 2026
Monthly visitors increased 76% MoM.
Recent news
Latest coverage and updates
- receives_financingAug 31, 2026
Mitochon Pharmaceuticals, Inc. received financing of $1M in grant on Aug 20th '26.
Mitochon Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mitochon Pharmaceuticals's valuation, stock price, and market status.
Is Mitochon Pharmaceuticals a public or private company?
Mitochon Pharmaceuticals is a private company.
What is the current stock price of Mitochon Pharmaceuticals?
Mitochon Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is Mitochon Pharmaceuticals worth (valuation)?
Valuation information for Mitochon Pharmaceuticals is not publicly available.
Can I buy Mitochon Pharmaceuticals stock?
Mitochon Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mitochon Pharmaceuticals's last funding round?
Mitochon Pharmaceuticals's most recent funding round was Grant on May 10, 2022.
Who are the main investors in Mitochon Pharmaceuticals?
Key investors in Mitochon Pharmaceuticals include Benjamin Franklin Technology Partners, Emily's Entourage, Cures Within Reach, BrightFocus Foundation, The Michael J. Fox Foundation for Parkinson's Research.
Will Mitochon Pharmaceuticals IPO soon?
No public IPO plans have been announced for Mitochon Pharmaceuticals.
How can I track Mitochon Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mitochon Pharmaceuticals's secondary market activity and sign up for updates.